The observed effects of UPF1 overexpression suggest that NMD enhancers may be effective in treating certain forms of ALS and raise the possibility that a similar principle may apply to other disorders caused by aberrant RNA processing. The gene discussed is PLA1A; the disease is amyotrophic lateral sclerosis.